ストックスクリーナーアプリを入手
16.50
0.00%
0.00
アフターアワーズ：
16.60
0.10
+0.61%
前日終値:
$16.50
開ける：
$16.66
24時間の取引高:
2.19M
Relative Volume:
1.13
時価総額：
$1.15B
収益：
$1.03B
当期純損益:
$-94.55M
株価収益率:
-11.78
EPS:
-1.4012
ネットキャッシュフロー:
$-3.64M
1週間 パフォーマンス:
+4.96%
1か月 パフォーマンス:
-19.75%
6か月 パフォーマンス:
-11.34%
1年 パフォーマンス:
+25.86%
1日の値動き範囲:
$16.27
$17.35
1週間の範囲:
$15.52
$17.35
52週間の値動き範囲:
$12.26
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
16.50 | 1.09B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-19 | アップグレード | Truist | Hold → Buy |
| 2026-03-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | アップグレード | Lake Street | Hold → Buy |
| 2026-02-20 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 再開されました | TD Cowen | Buy |
| 2025-12-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 再開されました | Stifel | Hold |
| 2025-09-08 | 開始されました | Oppenheimer | Outperform |
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
An insulin-delivery company will hold a results call Nov. 5 at 4:30 p.m. ET. - Stock Titan
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks - Yahoo Finance
TNDM Maintained by Citigroup -- Price Target Lowered to $20 - GuruFocus
Operating cash flow per share of Tandem Diabetes Care, Inc. – HAN:TD5A - TradingView
Tandem Diabetes Care, Inc. (0M0F.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tandem Diabetes (TNDM) Expands Mobi Insulin Delivery System to 1 - GuruFocus
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries - marketscreener.com
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - Nasdaq
A Look at Tandem Diabetes Care Inc (TNDM) After 3.3% Gain -- GF Value $24.10 vs Price $15.72 - GuruFocus
TNDM Maintained by Truist Securities -- Price Target Lowered to $28 - GuruFocus
Tandem Insulin Pump Lawsuit Alleges Delivery Failure Led to 15-Year-Old Girl’s Death - AboutLawsuits.com
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating - marketscreener.com
The Technical Signals Behind (TNDM) That Institutions Follow - Stock Traders Daily
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
A Look at Tandem Diabetes Care Inc (TNDM) After 6.4% Decline -- GF Value $24.09 vs Price $16.38 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return? - Yahoo Finance
Officer at Tandem Diabetes Care (NASDAQ: TNDM) plans 360-share stock sale - Stock Titan
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance Singapore
A Look at Tandem Diabetes Care Inc (TNDM) After 7.7% Gain -- GF Value $24.08 vs Price $17.54 - GuruFocus
(TNDM) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tandem Diabetes Care: Stop Paying For Tomorrow's ProfitsStrong Sell (NASDAQ:TNDM) - Seeking Alpha
Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
Zacks Investment Research - גלובס
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now - Yahoo Finance
(TNDM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
A Look at Tandem Diabetes Care Inc (TNDM) After 3.4% Decline -- GF Value $24.05 vs Price $20.56 - GuruFocus
Tandem Diabetes Care stock gains after recent rally in diabetes tech - ad-hoc-news.de
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Tandem Diabetes Care (TNDM) Edges Higher to $21.49, Holding Above Key SupportGrowth ETF - vinanet.vn
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Sahm
Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat? - TradingView
TNDM Initiated Coverage On by William Blair -- Rating Set to Out - gurufocus.com
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - Benzinga
William Blair initiates Tandem Diabetes stock with outperform rating By Investing.com - Investing.com Nigeria
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors - simplywall.st
Tandem (TNDM) Earnings Brief: Profit Per Share Clears Its Benchmark in the Current Update; Price Action: Shares Finish 6.63% Up at the CloseEarnings Season Preview - Vinanet
Tandem Diabetes Care CFO Leigh Vosseller Reports RSU Vesting Transactions on August 15, 2026 - Kalkine Media
Tandem Diabetes Care CEO John F. Sheridan Reports August 2026 RSU Vesting and Tax Withholding Details - Kalkine Media
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Sheridan John F - Moomoo
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Morrison Susan - Moomoo
Tandem Diabetes (TNDM) CFO vests RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) exec nets 475 shares after RSU vesting - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CEO vests 15,916 RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Kyrillos Jean-Claude - Moomoo
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
Tandem Diabetes Care Inc (TNDM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '26 |
Option Exercise |
0.00 |
4,120 |
0 |
52,982 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '26 |
Option Exercise |
0.00 |
15,916 |
0 |
165,315 |
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,827 |
0 |
53,283 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
1,010 |
0 |
30,825 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
2,425 |
| Carpenter Rick | EVP & Chief Technology Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,507 |
0 |
32,968 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
32,626 |
0.26%
0.38%
大文字化:
|
ボリューム (24 時間):